Altamira Therapeutics' Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal -February 07, 2024 at 08:47 am EST

HAMILTON, BERMUDA, Feb. 07, 2024 -- Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus vectors, commonly used in gene therapy, when integrating...

Related Keywords

Bermuda ,Switzerland ,Covadonga Pa ,Altamira Therapeutics Ltd ,Nasdaq ,Securities Exchange Commission ,Globenewswire Inc ,Securities Exchange ,Drug Administration ,Integrative Medicine ,Altamira Therapeutic Chief Operating ,Securities Act ,Securities Exchange Act ,Annual Report ,Exchange Commission ,Investor Contact ,Markets ,